semicochliodinol A

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesemicochliodinol A
Drug Alias Namesemicochliodinol B
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitorsEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1Human immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCiba Geigy Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCiba Geigy Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A